TRANSFORMING SURGICAL WAITLIST INTO A ‘PREPARATION LIST’
With
Dr Andrew Marks,
Staff Specialist Anaesthetist & Director of Perioperative Medicine,
Royal North Shore Hospital, Sydney, Australia
Dr Kanika Chaudhri,
Anaesthetic Senior Resident Medical Officer,
Royal North Shore Hospital, Sydney, Australia
CASE STUDY
Filmed in Sydney, Australia | January 2026
The DIAMONDS initiative aims to transform the surgical waitlist into a “preparation list,” enabling healthcare professionals to optimise patient care in the months leading up to elective surgery starting at pre-admission phase.
Patients are will be able to complete pre-admission forms online, receive timely updates, and access educational resources to ensure thorough preparation. This will allow staff to spend more time with patients.
The DIAMONDS pathway, which stands for ‘Digital Pathway of Improved Assessment, Management and Optimisation of Patients for Planned Surgery’ has commenced at Royal North Shore Hospital in Sydney, Australia.
patient care by streamlining assessments and addressing the challenges of the existing paper-based system.
“Staff benefit by having centralised patient information and automated routine tasks, allowing them to focus on providing high-quality care, which ultimately leads to a smoother, more efficient process for everyone involved”, says Dr Kanika Chaudhri.
“Patients benefit from user-friendly tools that enable them to complete pre-admission forms online and access educational resources, enhancing their care experience,” she said.
DIAMONDS is led by the New South Wales, Northern Sydney Local Health District, with collaboration partners Australian Institute of Health Innovation (AIHI) and the George Institute for Global Health.
Source: Adapted from NSLHD news and events
-
Next generation nanomedicine and radiopharmaceuticals to treat cancer
Finding better ways of treating cancer, aside from finding a cure, aim to provide a better quality of life for those who suffer from it.
Professor Thurecht’s work focuses on nanomedicine and spans across the Australian Institute for Bioengineering and Nanotechnology and the Centre for Advanced Imaging, at the University of Queensland in Australia.
-
Pancreatic and lung cancers driven by mutations in the cancer gene KRAS
Dr Mara Zeissig is a recently appointed Lab Head within the Tumour Inflammation and Immunotherapy Program at the South Australian immunoGENomics Cancer Institute (SAiGENCI).
Her research focuses on studying immune evasion mechanisms in lung and pancreatic cancers to identify novel ways to increase response to immunotherapy. Her expertise is in genetically engineered mouse models of lung cancer, CRISPR-Cas9 screening technologies and T cell based immunotherapies (e.g Checkpoint inhibitors). -
Clinical guidelines for diagnostics and early intervention in Primary Aldosteronism
Primary Aldosteronism (PA), or Conn Syndrome, is the most commonly under-diagnosed cause of high blood pressure affecting millions of people. Associate Professor Jun Yang’s goal is to facilitate the diagnosis of every case of PA and make treatment widely available to all communities including the disadvantaged.
